P3‐301: Dextromethorphan/quinidine (AVP‐923) phase 2 study for treatment of agitation in Alzheimer's disease: Comparing the enrolled agitation sample with the international psychogeriatric association definition of agitation in cognitive disorders (NCT01584440). (1st July 2015) - Cummings, Jeffrey L.; Lyketsos, Constantine; Peskind, Elaine R.; Porsteinsson, Anton P.; Mintzer, Jacobo E.; Scharre, Douglas W.; De La Gándara, José E.; Agronin, Marc; Davis, Charles S.; Nguyen, Uyen; Shin, Paul; Tariot, Pierre N.; et al.